NCT02703142

Brief Summary

Gastric conduit ischemia or anastomotic breakdown after esophagectomy with cervical esophagogastrostomy often cause severe complications, such as leakage, necrotic organs, and strictures. Thus, the purpose of this study is the safety and efficacy of endoscopic evaluation about reconstructive organs after esophagectomy. The investigators evaluate endoscopic predictions using classifications in acute phase after esophagogastrostomy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2015

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2015

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 18, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 9, 2016

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

October 18, 2016

Status Verified

October 1, 2016

Enrollment Period

1 year

First QC Date

January 18, 2016

Last Update Submit

October 16, 2016

Conditions

Keywords

esophagogastrostomygastric conduit ischemiaendoscopy

Outcome Measures

Primary Outcomes (3)

  • Number of participants with endoscopy-related adverse events as assessed by Clavien-Dindo Classification

    From 1 to 29 days after esophagectomy

  • Number of participants with the classification of gastric conduit ischemia by endoscopic findings

    From 1 to 15 days after esophagectomy

  • Number of participants with the major complications of gastric conduit (strictures, leakage, necrosis)

    From 1 to 29 days after esophagectomy

Secondary Outcomes (3)

  • Biological examination of the mucosal biopsy of gastric conduit as assessed by the ischemia related RNA copy number

    From 1 to 29 days after esophagectomy

  • Biological examination of the mucosal biopsy of gastric conduit as assessed by the scoring system for immunohistochemical staining

    From 1 to 29 days after esophagectomy

  • Biological examination of gastric conduit as assessed by the Mitochondrial DNA copy number

    From 1 to 29 days after esophagectomy

Study Arms (1)

Patients after esophagectomy

Endoscopic examinations are performed at 1, 8, and 15 postoperative days. Endoscopic examination is added when abnormal findings are demonstrated.

Procedure: Patients after esophagectomy

Interventions

postoperative endoscopic evaluation

Patients after esophagectomy

Eligibility Criteria

Age20 Years - 84 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients undergo an esophagectomy with reconstruction by a gastric pull-up for malignant or end-stage benign esophageal disease. The patients have a cervical esophagogastrostomy.

You may qualify if:

  • Malignant or end-stage benign esophageal disease.
  • Esophagectomy with reconstruction by a gastric pull-up.

You may not qualify if:

  • Severe heart failure and pulmonary dysfunction
  • Severe renal and liver dysfunction
  • Allergenic history
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nagasaki University Hospital

Nagasaki, Nagasaki, 852-8501, Japan

Location

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

dmp-DNA

MeSH Terms

Conditions

Esophageal NeoplasmsConstriction, PathologicAnastomotic LeakIschemia

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsDigestive System DiseasesEsophageal DiseasesGastrointestinal DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic Processes

Study Officials

  • Shinichiro Kobayashi

    Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences,

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

January 18, 2016

First Posted

March 9, 2016

Study Start

October 1, 2015

Primary Completion

October 1, 2016

Study Completion

October 1, 2016

Last Updated

October 18, 2016

Record last verified: 2016-10

Data Sharing

IPD Sharing
Will share

Locations